BRF (BRFS3) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Achieved record second quarter results with net revenue up 22.3% year-over-year, net income of R$1.1 billion, and free cash flow of R$1.7 billion, reversing prior year losses.
Adjusted EBITDA reached R$2.6 billion (17.6% margin), marking the sixth consecutive quarter of margin improvement and the best first-half result.
Net leverage dropped to 1.14x, the lowest in nine years, with strong operational efficiency gains and capital structure optimization.
Operational advances, brand investments, and commercial execution drove strong volume growth in Brazil and international markets.
ESG initiatives advanced, including 90% traceability of indirect grain suppliers, 35% clean energy usage, and top rankings in protein sector responsibility.
Financial highlights
Net revenue was R$14,930 million, up 22.3% year-over-year and 11.6% sequentially.
Adjusted EBITDA was R$2,621 million (17.6% margin), up 160.4% year-over-year.
Gross profit reached R$3,930 million, with a gross margin of 26.4%.
Free cash flow was R$1,728 million, up from negative R$694 million in 2Q23.
Net debt reduced to R$8,932 million, with leverage at 1.14x LTM Adjusted EBITDA.
Outlook and guidance
Focus remains on operational efficiency, innovation, and market expansion, with continued investment in ESG and new product launches.
Ongoing expansion in international markets, with 32 new export authorizations in the quarter and 57 in the first half.
ESG targets include achieving 50% clean electricity by 2030 and maintaining high supply chain traceability.
Optimism for maintaining volume growth and evaluating capacity expansion from 2025 onward.
Expectation of continued strong demand, new export permits, and favorable grain cost environment.
Latest events from BRF
- Record 3Q24: revenue up 12.4%, net income BRL 1.1B, leverage at historic low.BRFS3
Q3 202414 Jan 2026 - Record 2024 results: revenue, profit, and cash flow up, leverage down, global growth advanced.BRFS3
Q4 202427 Dec 2025 - Record profit, revenue growth, and a merger with a 0.8521 share exchange ratio announced.BRFS3
Q1 202526 Dec 2025 - Merger with Marfrig and record EBITDA highlight robust growth despite export challenges.BRFS3
Q2 202523 Nov 2025 - Record sales and revenue growth, but lower profit and margins amid higher costs and export bans.BRFS3
Q3 202517 Nov 2025